Patients with diabetes often develop pulmonary complications and FGF4, as a novel long-acting glucose-regulating factor, can not only effectively regulate blood glucose but also alleviate pulmonary inflammation and injury through its anti-inflammatory and antioxidant properties. The gene discussed is FGF4; the disease is diabetes mellitus.